715 related articles for article (PubMed ID: 23902838)
1. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.
Guo K; Lu J; Kou J; Wu M; Zhang L; Yu H; Zhang M; Bao Y; Chen H; Jia W
BMC Nephrol; 2015 Oct; 16():159. PubMed ID: 26449625
[TBL] [Abstract][Full Text] [Related]
4. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM
Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584
[TBL] [Abstract][Full Text] [Related]
6. [Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients].
Zhou Y; Guo LX; Yu DN; Zhou L; Wang Y; Mou ZQ; Wang XX; Zhang LN; Li M
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jun; 33(6):610-3. PubMed ID: 22883271
[TBL] [Abstract][Full Text] [Related]
7. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
8. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
9. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
10. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
11. Effect of exercise on albuminuria in people with diabetes.
Koh KH; Dayanath B; Doery JC; Polkinghorne KR; Teede H; Kerr PG
Nephrology (Carlton); 2011 Nov; 16(8):704-9. PubMed ID: 21854502
[TBL] [Abstract][Full Text] [Related]
12. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
13. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
[TBL] [Abstract][Full Text] [Related]
14. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].
Fu WJ; Zheng L; Wang Q; Deng RT; Ye CQ; Wang SB; Peng LF; Xiong SL; Tang HH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):878-81. PubMed ID: 21602148
[TBL] [Abstract][Full Text] [Related]
15. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
16. Increased leptin concentrations and lack of gender difference in Type 2 diabetic patients with nephropathy.
Chan WB; Ma RC; Chan NN; Ng MC; Lee ZS; Lai CW; Tong PC; So WY; Chan JC
Diabetes Res Clin Pract; 2004 May; 64(2):93-8. PubMed ID: 15063601
[TBL] [Abstract][Full Text] [Related]
17. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.
Ma X; Lu C; Lv C; Wu C; Wang Q
J Diabetes Res; 2016; 2016():6789402. PubMed ID: 26881255
[TBL] [Abstract][Full Text] [Related]
18. Familial factors in diabetic nephropathy: an offspring study.
Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
[TBL] [Abstract][Full Text] [Related]
19. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
20. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]